Home » Topics » BioWorld Science

BioWorld Science
RSS

Misfolded tau proteins differ by tauopathy

Sep. 5, 2018

SRC-3 shushes stem cells

Sep. 5, 2018

Daiichi Sankyo studies DS-8201a in phase III trials for advanced HER2-positive breast cancer

Sep. 4, 2018

IAVI enrolling healthy volunteers for first-in-human study of eOD-GT8 60mer vaccine, adjuvanted

Sep. 4, 2018

Janssen studies JNJ-67953964 in phase IIa for depression

Sep. 4, 2018

Jeil Pharmaceutical presents JP-1366, a potent potassium-competitive acid blocker for treating GERD

Sep. 4, 2018

An epigenetic signature in non-small cell lung cancer predicts response to anti-PD-1 therapy

Sep. 4, 2018

MHRA agrees in principle with proposed restart of Redx's phase I/IIa study of RXC-004

Sep. 4, 2018

Synthetic oligosaccharide conjugate vaccine for shigellosis evaluated in phase I trial

Sep. 4, 2018

ABX-464 shows promise in phase IIa trial in ulcerative colitis

Sep. 4, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...